Is this vaccine a cure for cancer?

No. It's an emerging treatment option, currently used alongside a broader, physician-guided treatment plan — mainly for patients who've already tried standard therapy. Early results are promising but based on small patient numbers.

What is EBV and how do I know if I have an EBV-related cancer?

Epstein-Barr virus is extremely common and usually harmless. Whether a specific cancer is "EBV-positive" is determined through lab testing of tumor tissue — it's not something you can tell from symptoms alone. Ask your oncologist whether EBV testing applies to your diagnosis.

Can I get this treatment outside China?

Not currently. WGc-043 is only available at its originating hospital inside the Boao Lecheng pilot zone in Hainan, China, under China's early-access regulatory framework.

How much does it cost?

Pricing is government price-filed for the vaccine itself, with the total cost depending on how many sessions are recommended and what diagnostic workup is needed. Get a written cost breakdown from the hospital or your coordinator before making a decision.

How is this different from CAR-T therapy?

CAR-T involves removing and re-engineering a patient's own immune cells in a lab before reinfusing them — a complex, individualized process. This vaccine is a simple injection that trains the immune system in place, without cell collection or engineering, making it faster and less invasive, though the two approaches aren't direct substitutes for each other.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

China Just Approved the World's First Cancer Vaccine for EBV-Related Tumors — Here's What It Means

ChinaCureLink

Fri Aug 21 2026

7 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page